• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Efftec International announces acquisition of Teligent Care, Inc.

Share:

December 10, 2018

Efftec International has acquired Teligent Care, Inc.

Pursuant to the terms of this transaction, shareholders of Teligent have been issued 7M restricted shares of Efftec.

The Company intends to change its name to “Teligent Care, Inc.” as well as seek a new ticker symbol to better reflect its new business model and enterprise.

In accordance with the terms of the acquisition agreement, Teligent’s CEO, Mr. Paul Cristiano, has joined Efftec as a member of its Board of Directors alongside Efftec’s current CEO, Bruce Collett.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: December 10, 2018

Source: SeekingAlpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Brightstar Capital Partners To Acquire Capstone Nutrition, A Leading Developer And Manufacturer Of Nutrition ProductsBrightstar Capital Partners To Acquire Capstone Nutrition, A Leading Developer And Manufacturer Of Nutrition Products
  • HIT Think How value-based care may provide an answer to addiction treatmentHIT Think How value-based care may provide an answer to addiction treatment
  • A New Health It Discipline: Social InformaticsA New Health It Discipline: Social Informatics
  • KKR Completes Acquisition of BrightSpring Health ServicesKKR Completes Acquisition of BrightSpring Health Services
  • ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology CompanyImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company
  • Cone Health Launches Innovation Center to Develop & Launch IdeasCone Health Launches Innovation Center to Develop & Launch Ideas
  • Viome acquires Habit from Campbell Soup Company to become the undisputed leader in personalized healthViome acquires Habit from Campbell Soup Company to become the undisputed leader in personalized health
  • BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy CompanyBioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications